MedElevator Войти в исследования
← Поиск публикаций

DOI 10.62438/tunismed.v102i12.5254

Медицинская библиотека · La Tunisie medicale · 2024

The (1,3)-β-D-glucan use for invasive candidiasis diagnosis in non-neutropenic critically ill patients: a prospective cohort study.

Tlili Badis, Trifi Ahlem, Kallel Aicha, Mehdi Asma, Seghir Eya, Messaoued Lynda, Kallel Kalthoum, Abdellatif Sami, Ben Lakhal Salah

СтатьяПеревод пока не подготовлен

Аннотация

UNLABELLED: Introduction Invasive candidiasis (IC) is a widespread infection in intensive care. As culture-based diagnostic techniques take several days before positivity and leaks of sensitivity. (1,3)-β-D-glucan (BDG) was proposed as a mycological criterion for IC diagnosis in selected patients.

AIM: To determine the performance of BDG assay in the early diagnosis of IC in non-neutropenic critically ill patients

Methods

We conducted a prospective evaluative study. All adults who were hospitalized in La Rabta Tertiary Hospital intensive care unit from January to June 2023 and at risk of IC were screened on a weekly basis. A true positive status corresponded to confirmed or highly probable IC and a positive BDG test (>80 pg/mL).

RESULTS

A total of 123 BDG tests were performed on 85 patients with a median age of 58 years [41.5-67.5] and a median SOFA score=3 [2-5.5]. The median colonization index was 0.16 [0-0.33], and Candida albicans was the most common species isolated (71%). The median Candida score was 0.9 [0-2.9]. IC was retained in 30 cases. The median BDG level was 98 pg/mL [24-275]. Sixty-one patients had a positive BDG test, in whom only 21 had an IC. The performance of the BDG test in the diagnosis of IC was moderate (AUC/ROC=0.68 [0.575-0.788], p=0.003). The discriminatory power was better with the negative prediction (PNV=85.5%).

CONCLUSION

The major benefit of BDG test in intensive care seems to lie in its NPV allowing to roll out the invasive candidiasis diagnosis then withhold or interrupt antifungal therapy.

Для цитирования: Tlili Badis, Trifi Ahlem, Kallel Aicha, Mehdi Asma, Seghir Eya, Messaoued Lynda, Kallel Kalthoum, Abdellatif Sami, Ben Lakhal Salah. The (1,3)-β-D-glucan use for invasive candidiasis diagnosis in non-neutropenic critically ill patients: a prospective cohort study.. La Tunisie medicale. 2024. DOI: 10.62438/tunismed.v102i12.5254.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.